— Conference call to be held Monday, July 13th at 8:00 a.m. E.T. — WALTHAM, Mass., July 10, 2026 /PRNewswire/ — Q32 Bio Inc. (Nasdaq: QTTB) (“Q32 Bio”), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (“AA”) and other autoimmune and…
Source: prnewswire
Country: United States